Conclusions: High-or moderate-intensity statin therapy at 1 year after revascularization for CLTI is associated with higher long-term survival. However, a significant proportion of these patients had their statin stopped or intensity of therapy decreased within the first postoperative year, resulting in a loss of this survival difference. These results demonstrate the importance not only of discharging this population on highor moderate-intensity statin therapy but also of maintaining this therapy postoperatively.
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Objective: Peripheral artery disease is a common comorbidity in patients with end-stage renal disease, but there is a paucity of data comparing outcomes of endovascular and open revascularization in this group of patients. In this study, we examined perioperative outcomes of lower extremity endovascular (LEE) revascularization and open lower extremity bypass (LEB) in patients on dialysis.
Methods: Patients on dialysis and undergoing LEE revascularization and LEB from 2011 to 2015 were identified in the American College of Surgeons National Surgical Quality Improvement Program targeted vascular data set. Patients' demographics, comorbidities, anatomic features, and perioperative outcomes were compared between LEE and LEB procedures.
Results: From 2011 to 2015, there were 1157 lower extremity revascularizations performed in dialysis patients. In this group, 608 were LEE (53%) and 549 were LEB (47%) procedures. Demographics such as age, sex, race, and body mass index were similar between the two groups (P > .05). Patients undergoing open and endovascular procedures had similar rate of comorbidities of hypertension, smoking, congestive heart failure, diabetes, chronic obstructive pulmonary disease, and bleeding disorders. Only 50 (4%) procedures were done emergently, and there was a similar rate in the two groups. A majority of the procedures (n ¼ 1033 [89.7%]) were done for critical limb ischemia. Preoperative aspirin and beta blocker use was higher in the LEE group, and statin use was similar between the two groups. Table I compares postoperative outcomes on univariate analysis between the two groups. On risk-adjusted multivariate analysis (Table II) , LEB was associated with a lower rate of major amputation but a higher rate of postoperative bleeding and wound complications. Thirty-day mortality and cardiovascular morbidity were similar between the two groups.
Conclusions: In dialysis patients, LEB is associated with a lower risk of major limb amputation but a higher rate of postoperative wound complications and bleeding compared with LEE revascularization. Cardiovascular complications, 30-day mortality, and reinterventions were similar in the two groups. In dialysis patients who are a good surgical risk and with an appropriate target, lower extremity bypass procedures should be strongly considered for infrainguinal revascularization to achieve better limb salvage. Longer term outcomes comparing the two types of procedures are needed.
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